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Abstract
Purpose The purpose of this study is to assess indocyanine
green angiographic findings in patients with nonfamilial
amyloidosis.
Methods The method used was a prospective study includ-
ing seven patients (14 eyes) with nonfamilial amyloidosis.
All patients underwent detailed ophthalmic clinical exami-
nation, fundus photography, and indocyanine green angiog-
raphy (ICGA). Fluorescein angiography (FA) was
performed in four patients.
Results Of the seven patients, four (57.1 %) were male.
Mean age was 49.5 years. Six patients had renal amyloidosis
and one patient had systemic amyloidosis. Mean best-
corrected visual acuity was 20/25. Fundus and FA findings
included cotton-wool spots (28.5 %), retinal hemorrhages
(14.3 %), retinal pigment epithelial changes (21.4 %), serous
retinal detachment (7.1 %), optic disk edema or staining
(7.1 %), area of peripheral retinal capillary non-perfusion
(7.1 %), disseminated peripheral punctiform hyperfluores-
cence (21.4 %), and subretinal pooling (7.1 %). Fundus
examination results were unremarkable in eight eyes
(57.1 %). ICGA showed abnormal findings in all eyes.
These included diffuse or focal/multifocal choroidal vascu-
lar staining appearing at the late phase and prevailing in
peripheral fundus (100 %), hyperfluorescent fleecy lesions
appearing at the late phase and also prevailing in peripheral
fundus (28.5 %), hypofluoresent areas of variable sizes
(85.7 %), and pinpoints (71.4 %).
Conclusions Our results show that a subclinical, fairly typ-
ical choroidal involvement, detectable only by ICGA, is
common in patients with nonfamilial amyloidosis. ICGA
may be useful in better understanding the pathogenesis of
amyloidosis choroidopathy and in establishing a diagnosis of
amyloidosis in atypical or incomplete clinical presentations.
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Introduction
Amyloidosis is a systemic disorder, characterized by an
aberrant deposition, in single or multiple organs, of
insoluble chains of polypeptides derived from a portion
of light chain of immunoglobulins [1]. It may affect one
(localized) or multiple organs (systemic) and can have a
family pedigree (familial). The underlying cause may be
unknown (primary), although amyloid can develop as a
consequence of chronic inflammatory or neoplastic con-
ditions (secondary amyloidosis) [1, 2].
Amyloid deposition has been reported in ocular
adnexae, orbit, and components of the globe such cor-
nea, iris, trabecular meshwork, sclera and vitreous body
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[2–4]. Choroidal involvement in patients with nonfamil-
ial amyloidosis (NFA) has been rarely described [5, 6].
The purpose of the present study was to assess prospec-
tively indocyanine green angiography (ICGA) features in
patients with NFA.
Methods
The study included seven consecutive patients (14 eyes) diag-
nosed with NFA and examined at Fattouma Bourguiba Univer-
sity Hospital (Monastir, Tunisia). The diagnosis of amyloidosis
Table 1 Demographic and clinical characteristics of patients
Patient no Age (years) Sex Type of amyloidosis Duration of the disease (years) Systemic hypertension Hemodialysis
1 43 M Primary/localized 4 − −
2 70 F Primary/localized 3 + +
3 65 M Secondary/localized 1 + −
4 36 F Primary/localized 1 − +
5 37 M Primary/systemic 15 − −
6 47 F Primary/localized 5 − +
7 49 M Primary/systemic <1 − −
M male, F female
Fig. 1 Patient 1. a Fundus
photograph of the right eye
shows retinal hemorrhages,
cotton-wool spots, and retinal
pigment epithelial changes in
the macular area. b Fundus
photograph of the left eye
shows retinal pigment epithelial
changes. Mid-phase fluorescein
angiogram of the left eye shows
retinal pigment epithelium
changes, retinal vascular leak-
age (c), and disseminated pe-
ripheral punctiform
hyperfluorescence (d). e Mid-
phase indocyanine green an-
giogram of the left eye showing
areas of macular hypofluores-
cence (white arrow heads). f
Late-phase indocyanine green
angiogram of the same eye
shows hyperfluorescent fleecy
lesions in the midperiphery
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was based on kidney biopsy in five patients, on colonic biopsy
in one patient, and on labial biopsy in one patient.
All patients underwent detailed ophthalmic evaluation
including measurement of Snellen best-corrected visual acu-
ity (BCVA), slit-lamp examination, tonometry, and dilated
fundus examination with non contact and contact lenses.
Fundus photography and ICGA were performed in all
patients. Fluorescein angiography (FA) was performed in
four patients.
The complete protocol was reviewed and approved by
the ethics and research committees of our institution, and all
patients provided informed consent.
Results
Of the seven patients, four (57.1 %) were male and three
(42.9%)were female. The patients’ ages ranged from 36 years
to 70 years (mean, 49.5 years). The demographic character-
istics and systemic manifestations are listed in Table 1. Dura-
tion of the disease ranged from few months to 15 years. Five
patients had localized renal amyloidosis and two patients had
systemic amyloidosis with renal and colonic involvement for
the first one (patient 5) and cardiac and hepatic involvement
for the second one (patient 7). Amyloidosis was primary in 6
patients and secondary to tuberculosis in 1 patient. Two
patients (28.5 %) had systemic hypertension and 3 patients
(42.8 %) were hemodialysed for advanced kidney failure.
No patient had ocular complains except one patient (pa-
tient 7) who experienced a decrease in visual acuity in his
right eye few days before examination. BCVA ranged from
light perception to 20/20 (mean, 20/25).
Fundus findings included cotton-wool spots (4 eyes; 28.5%;
Figs. 1a and 2a), retinal hemorrhages (2 eyes; 14.3 %; Fig. 1a),
retinal pigment epithelial changes (3 eyes; 21.4 %; Figs. 1a
and b), serous retinal detachment (1 eye; 7.1 %), and optic disc
edema (1 eye; 7.1 %). Fundus examination was normal in eight
eyes (57.1%). No cases of conjunctival involvement or vitreous
opacities were recorded in our patients.
FA revealed retinal pigment epithelial changes (3 eyes;
21.4 %; Fig. 1c), optic disc staining (1 eye; 7.1 %), subretinal
pooling (1 eye; 7.1 %), limited area of peripheral retinal capil-
lary non-perfusion (1 eye; 7.1 %), and disseminated peripheral
punctiform hyperfluorescence (3 eyes, 21.4 %; Fig. 1d).
ICGA showed choroidal involvement in all eyes (Table 2).
Diffuse choroidal vascular staining was observed in all eyes. It
presented in the form of hyperfluorescent streaks that became
visible at the late phase, predominating in peripheral fundus
and appearing to closely follow the course of choroidal vessels
(Fig. 2c). Focal/multifocal choroidal vascular staining were
observed in six eyes (42.8 %; Fig. 2b).
Other ICGA findings included hyperfluorescent fleecy
lesions appearing at the late phase and also predominating in
peripheral retina in 4 eyes (28.5 %; Fig. 1f), multiple punctu-
ate hyperfluorescences or pinpoints in 10 eyes (71.4 %;
Fig. 2b), and hypofluoresent areas of variable sizes in 12 eyes
(85.7 %; Fig. 1e).
Discussion
Ocular involvement in amyloidosis is uncommon including
corneal opacities, secondary glaucoma, pupillary disturbances,
recurrent subconjunctival hemorrhages, recurrent periocular
subcutaneous hemorrhages, conjunctival infiltration, sicca syn-
drome, ptosis, proptosis or globe displacement, periocular mass
or tissue infiltration, limitations in ocular motility and diplopia,
Fig. 2 Patient 4. a Fundus photograph of the left eye shows a cotton-
wool spot (black arrow). Late-phase indocyanine green angiogram
shows pinpoints with multifocal choroidal vascular staining (b) and
hyperfluorescent streaks that closely follow the course of choroidal
vessels in the midperiphery (c)
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vitreous deposits, retinal hemorrhages, cotton-wool spots, pin-
point white amyloid opacities over the retinal surface, sheathing
of retinal vessels, and retinal vascular closure [2, 7–12].
Choroidal involvement in NFA has been rarely described
in literature, and reported findings include hypofluorescent
areas with hypofluorescent lines in the midperiphery, hyper-
fluorescent streaks in the peripapillary area [5], and diffuse
occlusion of the choriocapillaris [6].
To the best of our knowledge, our series is the largest and the
first to characterize and analyze prospectively ICGA findings in
patients with NFA. Our data show that a subclinical choroidal
involvement is common in amyloidosic patients. Diffuse or
focal/multifocal choroidal vascular staining appearing at the
late phase and predominating in peripheral funduswas themain
finding, occurring in all eyes. Similar findings were previously
described in few patients with familial amyloidotic polyneur-
opathy [11, 12]. Other common findings in our series included
hyperfluorescent fleecy lesions, appearing at the late phase and
predominating in peripheral fundus, and pinpoints.
Diffuse or focal/multifocal choroidal vascular stainingmight
correspond to hyperfixation of indocyanine green (ICG) dye by
deposits of amyloid substance in choroidal vessels. As well,
pinpoints and fleecy lesions could correspond to hyperfixation
of ICG dye by deposits of amyloid substance in the chorioca-
pillaris stroma and retinal pigment epithelium. In fact, histo-
pathological studies confirmed that amyloid substance is
synthesized by retinal pigment epithelium with deposition of
amyloid seeping through retinal vessels into vitreous and in the
choriocapillaris [11, 13].
Hypofluoresent areas of variable sizes were encountered in
over 80 % of our patients. They might be caused by choroidal
vascular occlusion that could result from the amyloidosis
itself, the subsequent nephritis, observed in six patients, and/
or systemic hypertension, observed in two patients.
No case of vitreous opacity was recorded in our series.
Indeed, amyloid deposition in the vitreous is usually associ-
ated with the hereditary amyloidoses rather than NFA [2, 3].
In conclusion, amyloidosis choroidopathy may present
with a wide spectrum of subclinical ICGA findings. ICGA
may be useful in assessing and quantifying the extent of
amyloidosis choroidopathy and in better understanding its
pathogenesis. It may also help establish diagnosis in chal-
lenging cases of amyloidosis. Additional studies are re-
quired to clarify further the role of ICGA in diagnosing
amyloidosis and evaluating its severity.
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Table 2 Funduscopic, fluorescein, and ICG angiographic findings in patients with nonfamilial amyloidosis
Patient
no
Funduscopic findings Fluorescein angiographic findings ICG angiographic findings
1 Cotton-wool spots OU; retinal
hemorrhages OU; RPE
changes OU
RPE changes OU; disseminated
peripheral punctiform
hyperfluorescence OU
Diffuse choroidal vascular staining OU;
hyperfluorescent fleecy lesions OU; pinpoints OU;
areas of hypofluorescence OU
2 None Not done Diffuse choroidal vascular staining OU; focal/
multifocal choroidal vascular staining OD; areas of
hypofluorescence OU
3 None Area of peripheral retinal capillary non-
perfusion
Diffuse choroidal vascular staining OU; pinpoints OU;
areas of hypofluorescence OU
4 Cotton-wool spots OS Not done Diffuse choroidal vascular staining OU; focal/
multifocal choroidal vascular staining OS; pinpoints
OU; areas of hypofluoresence OU
5 RPE changes OD RPE changes OD Diffuse choroidal vascular staining OU; focal/
multifocal choroidal vascular staining OU; pinpoints
OU; areas of hypofluorescence OU
6 None Not done Diffuse choroidal vascular staining OU; focal/
multifocal choroidal vascular staining OS
7 Cotton-wool spots OD; optic
disc staining OD; serous
retinal detachment OD




Diffuse choroidal vascular staining OU; focal/
multifocal choroidal vascular staining OS;
hyperfluorescent fleecy lesions OU; pinpoints OU
ICG indocyanine green, RPE retinal pigment epithelial, OD right eye, OS left eye, OU both eyes
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